MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
23 hedge funds and large institutions have $14.1M invested in MorphoSys AG American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
17% more capital invested
Capital invested by funds: $12M → $14.1M (+$2.08M)
5% more funds holding
Funds holding: 22 → 23 (+1)
73% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$625K |
| 2 |
ABG
Ally Bridge Group
New York
|
+$491K |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$353K |
| 4 |
Millennium Management
New York
|
+$210K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
-$281K |
| 2 |
BlackRock
New York
|
-$223K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$195K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$155K |
| 5 |
Morgan Stanley
New York
|
-$78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
US Bancorp
Minneapolis,
Minnesota
| – | -$9.2K | -1,780 | -98% |
|
|
PA
27
Parallel Advisors
San Francisco,
California
| – | -$7K | -1,524 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | +$26 | +5 | New |
|
MOR Hedge Fund Activity: Q3 2022 in Review
23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q3 2022, worth a combined $14.1M — up 17% from $12M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MOR positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 11 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $625K. The largest seller was Optiver Holding, cutting an estimated $281K.
- 23 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q3 2022, up from 22 in Q2 2022.
- Funds reported $14.1M of MorphoSys AG American Depositary Shares stock for Q3 2022, up 17% quarter-over-quarter.
- 6 funds opened new MorphoSys AG American Depositary Shares positions in Q3 2022 and 5 closed out, a net change of +1 holder.
- The largest MorphoSys AG American Depositary Shares buyer in Q3 2022 was Opaleye Management, an estimated $625K added.
- The largest MorphoSys AG American Depositary Shares seller in Q3 2022 was Optiver Holding, an estimated $281K sold.
Based on aggregated 13F filings for Q3 2022.